72 results
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
in Operations and Research and Development. Before his tenure at Bristol-Myers, he served as a Manufacturing Manager for Procter & Gamble. He served … previously established a research and development committee, which was dissolved in September 2023. Each of these committees operates under a charter
424B5
SYRS
Syros Pharmaceuticals Inc.
19 Dec 23
Prospectus supplement for primary offering
4:53pm
corporate purposes unless otherwise indicated in the applicable prospectus supplement. General corporate purposes may include research and development
424B5
8twbugl3
1 May 23
Prospectus supplement for primary offering
4:06pm
8-K/A
EX-99.3
73g h80ct21g
30 Nov 22
Financial Statements and Exhibits
6:46pm
8-K
m7qd nl3u
16 Sep 22
Syros Announces Closing of Merger with Tyme Technologies and Concurrent Private Placement
4:15pm
425
jioobg9uo9
15 Sep 22
Business combination disclosure
4:08pm
8-K
EX-99.1
avb2pe
15 Sep 22
Departure of Directors or Certain Officers
4:06pm
424B3
mogesy5js
8 Aug 22
Prospectus supplement
5:47pm
S-4
8i89v3uiphrdub
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
S-4
EX-10.5
7tbtjtdd4j igk6
18 Jul 22
Registration of securities issued in business combination transactions
7:58am